Has bullous pemphigoid been reported with Saxagliptin?

Bullous pemphigoid requiring hospitalisation has been reported after marketing with DPP4 inhibitors, including Saxagliptin; if blisters or erosions develop and bullous pemphigoid is suspected, Saxagliptin should be discontinued and dermatology referral considered for diagnosis and appropriate treatment.